Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Ansari Astaneh MR, Shokoohi Rad S, Ghavami Shahri SH, Heidarzadeh HR. Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer. J Oncol Pharm Pract 2023;29:489-492. [PMID: 35730198 DOI: 10.1177/10781552221110472] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

For:	Ansari Astaneh MR, Shokoohi Rad S, Ghavami Shahri SH, Heidarzadeh HR. Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer. J Oncol Pharm Pract 2023;29:489-492. [PMID: 35730198 DOI: 10.1177/10781552221110472] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

Number

Cited by Other Article(s)

Sauer L, Bernstein PS. Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye. Ophthalmol Retina 2023;7:97-100. [PMID: 36496296 DOI: 10.1016/j.oret.2022.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2022] [Revised: 10/18/2022] [Accepted: 10/20/2022] [Indexed: 12/14/2022]